Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L

Peptide vaccines derived from CD8(+) T-cell epitopes have shown variable efficacy in cancer patients. Thus, some peptide vaccines are capable of activating CD8(+) T-cell responses, even in the absence of CD4(+) T-cell epitopes or dendritic cell (DC)-activating adjuvants. However, the mechanisms unde...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Llopiz, Diana, Huarte, Eduardo, Ruiz, Marta, Bezunartea, Jaione, Belsúe, Virginia, Zabaleta, Aintzane, Lasarte, Juan J, Prieto, Jesús, Borrás-Cuesta, Francisco, Sarobe, Pablo
Formato: Artigo
Idioma:Inglês
Publicado: Landes Bioscience 2013
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3897504/
https://ncbi.nlm.nih.gov/pubmed/24498563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares